TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
HRMY

Harmony Biosciences Holdings

Healthcare · Biotechnology

39.30$ -1.8% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement HRMY
Line item 2018 2019 2020 2021 2022 2023 2024 2025
– – +2,564.6% +91.2% +43.4% +32.9% +22.8% +21.5%
– +757.1% +1,658.9% +100.2% +50.4% +45.2% +29.3% +26.5%
– – +2,887.9% +89.3% +41.8% +30.0% +21.1% +20.1%
– +462.5% -72.1% +56.1% +133.4% +7.3% +91.7% +30.0%
– +198.3% +9.2% +60.8% +31.5% +13.4% +15.8% +38.2%
– +262.8% -23.5% +41.2% +44.2% +14.8% +36.6% +25.8%
– – – +415.3% +37.3% +59.8% -0.6% +9.2%
– – +364.7% -14.3% -22.3% +26.4% -26.4% -16.3%
– – – – +179.7% +65.6% +10.6% +12.1%
– +294.1% +145.5% -81.0% -2,812.2% – +4.0% +21.7%
– – – – +424.5% -29.0% +12.9% +9.1%
– – – +5,218.0% +82.5% +50.8% +5.4% +9.3%

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?